Log in to save to my catalogue

Feasibility of a Clinical Decision Support Tool for Ustekinumab to Predict Clinical Remission and Re...

Feasibility of a Clinical Decision Support Tool for Ustekinumab to Predict Clinical Remission and Re...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2674005869

Feasibility of a Clinical Decision Support Tool for Ustekinumab to Predict Clinical Remission and Relapse in Patients With Crohn’s Disease: A Multicenter Observational Study

About this item

Full title

Feasibility of a Clinical Decision Support Tool for Ustekinumab to Predict Clinical Remission and Relapse in Patients With Crohn’s Disease: A Multicenter Observational Study

Publisher

US: Oxford University Press

Journal title

Inflammatory bowel diseases, 2023-04, Vol.29 (4), p.548-554

Language

English

Formats

Publication information

Publisher

US: Oxford University Press

More information

Scope and Contents

Contents

Abstract
Background
Ustekinumab was recently approved for the treatment of moderate to severe Crohn’s disease (CD). Although the ustekinumab Clinical Decision Support Tool (UST-CDST) was able to predict ustekinumab responsiveness in a clinical trial, it is not clear whether UST-CDST can also predict a future clinical relapse following ustekin...

Alternative Titles

Full title

Feasibility of a Clinical Decision Support Tool for Ustekinumab to Predict Clinical Remission and Relapse in Patients With Crohn’s Disease: A Multicenter Observational Study

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2674005869

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2674005869

Other Identifiers

ISSN

1078-0998

E-ISSN

1536-4844

DOI

10.1093/ibd/izac105

How to access this item